Globus Medical (GMED +14.0%) reports Q2 worldwide sale of $148.9M, a drop of 23.4% Y/Y, however, beating consensus by $45.3M.
Sales in the U.S., including robotics, decreased by 21.8%.
International sales decreased by 31.2%
Company generated net cash provided by operating activities of $23.1M
Cash, cash equivalents and marketable securities of $636.2M.
GAAP net loss was $20.8M, a decrease of 154.6%, EPS of -$0.21 vs $0.38 during the same period last year.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.